Molecular Targets of Cannabidiol in Neurological Disorders
Open accessThe DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–266 of 266
Metabotropic glutamate receptors in neurodegeneration/neuroprotection: Still a hot topic?
Caraci, F., Battaglia, G., Sortino, M. A., Spampinato, S. F., Molinaro, G., Copani, A., Nicoletti, F., & Bruno, V. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.01.017 · Cited by 83
Gangarossa, G., Laffray, S., Bourinet, E., & Valjent, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00092 · Cited by 83
Bhaskaran, M. D., & Smith, B. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010683 · Cited by 82
Piperine exerts anti-seizure effects via the TRPV1 receptor in mice
Chen, C.-Y., Li, W., Qu, K., & Chen, C.-R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.041 · Cited by 82
Terrando, N., Yang, T., Ryu, J. K., Newton, P. T., Monaco, C., Feldmann, M., Ma, D., Akassoglou, K., & Maze, M. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00143 · Cited by 80
Mechanisms of N‐methyl‐ d ‐Aspartate Receptor Inhibition by Melatonin In the Rat Striatum
Escames, G., León, J., López, L. C., & Acuña-Castroviejo, D. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01250.x · Cited by 73
Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies
Manczak, M., Sheiko, T., Craigen, W. J., & Reddy, P. H. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130761 · Cited by 71
A critical role for glycine transporters in hyperexcitability disorders
Harvey, R. J., Carta, E., Pearce, B. R., Chung, S.-K., Supplisson, S., Rees, M. I., & Harvey, K. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.001.2008 · Cited by 71
Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease
Xiong, W., Chen, S.-R., He, L., Cheng, K., Zhao, Y.-L., Chen, H., Li, D., Homanics, G. E., Peever, J. H., Rice, K. C., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3615 · Cited by 70
Role of PPAR γ in the Differentiation and Function of Neurons
Quintanilla, R. A., Utreras, E., & Cabezas-Opazo, F. A. (2014) · PPAR Research · doi:10.1155/2014/768594 · Cited by 70
Vashishta, A., Habas, A., Pruunsild, P., Zheng, J.-J., Timmusk, T., & Hetman, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4873-09.2009 · Cited by 69
Cannabimimetic fatty acid derivatives in cancer and inflammation.
di Marzo, V., Melck, D., de Petrocellis, L., & Bisogno, T. (2000) · Prostaglandins & other lipid mediators · doi:10.1016/s0090-6980(00)00054-x · Cited by 67
Calcium Channelopathies: Voltage-Gated Calcium Channels
Adams, P. J., & Snutch, T. P. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_8 · Cited by 63
Genetic background of febrile seizures
Saghazadeh, A., Mastrangelo, M., & Rezaei, N. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0053 · Cited by 63
Jenny, M., Santer, E., Pirich, E., Schennach, H., & Fuchs, D. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.004 · Cited by 62
AlSharari, S. D., Freitas, K., & Damaj, M. I. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.018 · Cited by 62
Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy
Theodore, W. H., Wiggs, E. A., Martinez, A. R., Dustin, I. H., Khan, O. I., Appel, S. A., Reeves‐Tyer, P., & Sato, S. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03309.x · Cited by 61
A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors
Randall-Thompson, J., Pescatore, K. A., & Unterwald, E. M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1980-y · Cited by 61
The control of brain mitochondrial energization by cytosolic calcium: The mitochondrial gas pedal
Gellerich, F. N., Gizatullina, Z., Gainutdinov, T., Muth, K., Seppet, E., Orynbayeva, Z., & Vielhaber, S. (2013) · IUBMB Life · doi:10.1002/iub.1131 · Cited by 59
Rahimi, A., Moghaddam, A. H., & Roohbakhsh, A. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12099 · Cited by 59
von Rüden, E., Jafari, M., Bogdanović, R. M., Wotjak, C. T., & Potschka, H. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.001 · Cited by 56
Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation
Wheal, A. J., Cipriano, M., Fowler, C. J., Randall, M. D., & O’Sullivan, S. E. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217125 · Cited by 56
Jiang, W., Du, B., Chi, Z., Ma, L., Wang, S., Zhang, X., Wu, W., Wang, X., Xu, G., & Guo, C. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21384 · Cited by 56
Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
Sramek, J. J., Tansman, M., Suri, A., Hornig, M., Amsterdam, J. D., Stahl, S. M., Weisler, R. H., & Cutler, N. R. (1996) · PubMed · Cited by 55
Marijuana extracts possess the effects like the endocrine disrupting chemicals
Watanabe, K., Motoya, E., Matsuzawa, N., Funahashi, T., Kimura, T., Matsunaga, T., Arizono, K., & Yamamoto, I. (2004) · Toxicology · doi:10.1016/j.tox.2004.08.005 · Cited by 54
Opiate-induced seizures: A study of μ and δ specific mechanisms
Snead, O. C. (1986) · Experimental Neurology · doi:10.1016/0014-4886(86)90195-0 · Cited by 52
Transient Receptor Potential Ion Channels: Powerful Regulators of Cell Function
Billeter, A. T., Hellmann, J. L., Bhatnagar, A., & Polk, H. C. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a6359c · Cited by 52
Valvassori, S. S., Bavaresco, D. V., Scaini, G., Varela, R. B., Streck, E. L., Chagas, M. H., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A., & Quevedo, J. (2013) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2012-0886 · Cited by 50
Shirazi, M., Izadi, M., Amin, M., Rezvani, M. E., Roohbakhsh, A., & Shamsizadeh, A. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1689-5 · Cited by 48
The Endocannabinoid System: A Putative Role in Neurodegenerative Diseases
Iorio, G. D., Lupi, M., Sarchione, F., Matarazzo, I., Santacroce, R., Petruccelli, F., Martinotti, G., & Giannantonio, M. D. (2013) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.9222 · Cited by 47
Opiates Modulate Thermosensation by Internalizing Cold Receptor TRPM8
Shapovalov, G., Gkika, D., Devilliers, M., Kondratskyi, A., Gordienko, D. V., Busserolles, J., Bokhobza, A., Eschalier, A., Skryma, R. N., & Prevarskaya, N. B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.002 · Cited by 47
Effect of infused adenosine on cardiac output and systemic resistance in normal subjects.
Bush, A., Busst, C., Clarke, B., & Barnes, P. J. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05347.x · Cited by 47
Takeda, S., Usami, N., Yamamoto, I., & Watanabe, K. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026930 · Cited by 46
Zaharı, Z., & Ismail, R. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rv-032 · Cited by 45
Li, L., Hao, J. X., Fredholm, B. B., Schulte, G., Wiesenfeld‐Hallin, Z., & Xu, X.-J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.045 · Cited by 45
Alves, F. H. F., Crestani, C. C., Gomes, F. V., Guimarães, F. S., Corrêa, F. M. D. A., & Resstel, L. B. M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.05.003 · Cited by 44
Dawbarn, D., Harmar, A. J., & PYCOCK, C. (1981) · Neuropharmacology · doi:10.1016/0028-3908(81)90006-x · Cited by 44
Coomber, B., O’Donoghue, M., & Mason, R. J. (2008) · Synapse · doi:10.1002/syn.20547 · Cited by 42
Kong, W., Min, J., Liu, Y., Li, J., He, X., & Peng, B. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.10.022 · Cited by 40
Activation of phospholipase A2 by cannabinoids: Lack of correlation with CNS effects
EVANS, A. T., Formukong, E. A., & Evans, F. J. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81420-5 · Cited by 39
Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease
Öhrfelt, A., Andreasson, U., Simon, A., Zetterberg, H., Edman, Å., Potter, W., Holder, D., Devanarayan, V., Seeburger, J., Smith, A. D., et al. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000323417 · Cited by 38
Pahnke, J., Fröhlich, C., Krohn, M., Schumacher, T., & Paarmann, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.007 · Cited by 38
Endocannabinoid signalling in Alzheimer's disease
Maroof, N., Pardon, M., & Kendall, D. A. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130140 · Cited by 37
Lin, Y., & Hsieh, C. (2014) · Mediators of Inflammation · doi:10.1155/2014/493480 · Cited by 35
Lehto, S. G., Weyer, A. D., Zhang, M., Youngblood, B. D., Wang, L., Wang, W., Kerstein, P. C., Davis, C. D., Wild, K. D., Stucky, C. L., et al. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1090-9 · Cited by 34
Uslaner, J. M., Smith, S. M., Huszar, S. L., Pachmerhiwala, R., Hinchliffe, R. M., Vardigan, J. D., Nguyen, S. J., Surles, N. O., Yao, L., Barrow, J. C., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.015 · Cited by 34
Deutsch, S. I., Burket, J. A., & Benson, A. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.05.011 · Cited by 34
Spinal actions of ω‐conotoxins, CVID , MVIIA and related peptides in a rat neuropathic pain model
Jayamanne, A., Jeong, H. J., Schroeder, C. I., Lewis, R. J., Christie, M. J., & Vaughan, C. W. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12251 · Cited by 33
Differential expression of cytochrome P450 enzymes from the CYP2C subfamily in the human brain
Booth Depaz, I. M., Toselli, F., Wilce, P. A., & Gillam, E. M. J. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061242 · Cited by 29 · cited 1×
“It is unclear whether this is involved in the therapeutic effect of CBD in CNS disorders as evidence of CYP2C19 expression in brain remains conflicted [58, 59].”
BackgroundBrinckmann, A., Weiß, C., Wilbert, F., von Moers, A., Zwirner, A., Stoltenburg, G., Wilichowski, E., & Schuelke, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013513 · Cited by 29
Koch, M., Dehghani, F., Habazettl, I., Schomerus, C., & Korf, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03873.x · Cited by 28
Samineni, V. K., Premkumar, L. S., & Faingold, C. L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.041 · Cited by 28
Gomes, F. V., Alves, F. H. F., Guimarães, F. S., Correa, F. M. A., Resstel, L. B. M., & Crestani, C. C. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.007 · Cited by 27
Capsaicin-sensitive vasodilatatory mechanisms in the rat substantia nigra and striatum
Haj�s, M., Engberg, G., Nissbrandt, H., Magnusson, T., & Carlsson, A. C. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244779 · Cited by 27
Gong, S., Liang, Q., Zhu, Q., Ding, D., Yin, Q.-Z., Tao, J., & Jiang, X. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.11.222 · Cited by 27
Modulation of adenosinergic system and its application for the treatment of epilepsy
Świąder, M., Kotowski, J., & Łuszczki, J. J. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.10.005 · Cited by 26
Özkanlar, S., Kara, A., Şengül, E., Şi̇mşek, N., Karadeniz, A., & Kurt, N. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1548937 · Cited by 25
Shu, H., Yu, S., Zhang, C., Liu, S., Wu, K., Zang, Z., Yang, H., Zhou, S., & Yin, Q. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.04.007 · Cited by 23
Yamaori, S., Okushima, Y., Masuda, K., Kushihara, M., Katsu, T., Narimatsu, S., Yamamoto, I., & Watanabe, K. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00183 · Cited by 22
Bourin, M., & Dhonnchadha, B. Á. N. (2005) · Drug Development Research · doi:10.1002/ddr.20016 · Cited by 19
Magnesium sulfate effect on erythrocyte membranes of asphyxiated newborns
Szemraj, J., Sobolewska, B., Gulczyńska, E., Wilczyński, J., & Żylińska, L. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.02.005 · Cited by 16
Gilbert, J. C., Pertwee, R. G., & Wyllie, M. G. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb07727.x · Cited by 15
Stimulation of sphingomyelin hydrolysis by cannabidiol in fibroblasts from a Niemann-Pick patient
BURSTEIN, S. H., Hunter, S. A., & Renzulli, L. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90702-2 · Cited by 14
Pomponi, M. F. L., Gambassi, G., Pomponi, M., Gioia, A. D., & Masullo, C. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.09.003 · Cited by 14
Baddack, U., Frahm, S., Antolin‐Fontes, B., Grobe, J., Lipp, M., Müller, G., & Ibáñez-Tallon, I. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39094 · Cited by 12
Austgen, J. R., & Kline, D. D. (2013) · Brain Research · doi:10.1016/j.brainres.2013.09.006 · Cited by 9
Cited by
Thiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30136-3 · Cited by 905
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 818
The pharmacokinetics and the pharmacodynamics of cannabinoids
Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724
Bonini, S. A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M., & Mastinu, A. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.004 · Cited by 669
Iffland, K., & Grotenhermen, F. (2017) · Cannabis & Cannabinoid Research · doi:10.1089/can.2016.0034 · Cited by 645
Metadata
- Authors
- Ibeas Bih, C., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M., & Whalley, B. J.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 12
- Issue
- 4
- Pages
- 699-730
- ISSN
- 1878-7479 (ISSN-L)
- OpenAlex
- W1166458116
- Cited by
- 578
- References
- 266
- FWCI
- 16.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.